Burow; Matthew E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Burow; Matthew E..The latest application filed is for "combretum laurifolium mart. extract and methods of extracting and using such extract".

Company Profile

1.11.21

Burow; Matthew E. - Slidell LA
Burow; Matthew E. - New Orleans LA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combretum Laurifolium Mart. Extract And Methods Of Extracting And Using Such Extract App 20190388489 - Koepke; Peter ; et al.	2019-12-26
Daidzein analogs as treatment for cancer Grant 9,669,004 - Wang , et al. June 6, 2	2017-06-06
Combretum Laurifolium Mart, Extract And Methods Of Extracting And Using Such Extract App 20160339068 - Koepke; Peter ; et al.	2016-11-24
Postharvest production and enhancement of resveratrol and piceatannol in sugarcane Grant 9,227,898 - Boue , et al. January 5, 2	2016-01-05
Novel Daidzein Analogs As Treatment For Cancer App 20150148409 - WANG; Guangdi ; et al.	2015-05-28
Compositions and methods for treating obesity and diabetes Grant 8,987,198 - Burow , et al. March 24, 2	2015-03-24
Daidzein analogs as treatment for cancer Grant 8,962,679 - Wang , et al. February 24, 2	2015-02-24
Postharvest production and enhancement of resveratrol and piceatannol in sugarcane App 20150005533 - Boue; Stephen M. ; et al.	2015-01-01
Combretum Laurifolium Mart. Extract And Methods Of Extracting And Using Such Extract App 20140178506 - Koepke; Peter ; et al.	2014-06-26
Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof Grant 8,563,599 - Erhardt , et al. October 22, 2	2013-10-22
Novel Daidzein Analogs As Treatment For Cancer App 20130184475 - Wang; Guangdi ; et al.	2013-07-18
Glyceollins Suppress Androgen-Responsive Prostate Cancer App 20130041022 - Cleveland; Thomas E. ; et al.	2013-02-14
Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis Grant 8,323,706 - Cleveland , et al. December 4, 2	2012-12-04
Combretum Laurifolium Mart. Extract And Methods Of Extracting And Using Such Extract App 20120237619 - Koepke; Peter ; et al.	2012-09-20
Compositions and Methods for Treating Obesity and Diabetes App 20110237505 - BUROW; Matthew E. ; et al.	2011-09-29
Methods For Synthesizing Glycinols, Glyceollins I And Ii, Compositions Of Selected Intermediates, And Therapeutic Uses Thereof App 20110144195 - Erhardt; Paul W. ; et al.	2011-06-16
Combretum laurifolium Mart. extract and methods of extracting and using such extract Grant 7,879,369 - Koepke , et al. February 1, 2	2011-02-01
Combretum Laurifolium Mart. Extract And Methods Of Extracting And Using Such Extract App 20100047354 - Koepke; Peter ; et al.	2010-02-25
Combretum Laurifolium Mart. Extract And Methods Of Extracting And Using Such Extract App 20090074891 - Koepke; Peter ; et al.	2009-03-19
Spondias Mombin L. Extract And Methods Of Extracting And Using Such Extract App 20090035395 - KOEPKE; Peter ; et al.	2009-02-05
Maytenus Abenfolia Extract And Methods Of Extracting And Using Such Extract App 20090017140 - Koepke; Peter ; et al.	2009-01-15
Campsiandra Angustifolia Extract And Methods Of Extracting And Using Such Extract App 20090011060 - Koepke; Peter ; et al.	2009-01-08
Salacia Cuspidata Extract And Methods Of Extracting And Using Such Extract App 20090004310 - Koepke; Peter ; et al.	2009-01-01
Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis App 20080200537 - Cleveland; Thomas E. ; et al.	2008-08-21
Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis App 20060246162 - Cleveland; Thomas E. ; et al.	2006-11-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.